Efficacy of different dosing schedules of capecitabine for metastatic breast cancer: a single-institution experience.
Suresh A, Ganju A, Morgan E, Palettas M, Stephens JA, Liu J, Berger M, Vargo C, Noonan A, Reinbolt R, Cherian M, VanDeusen J, Sardesai S, Wesolowski R, Stover DG, Lustberg M, Ramaswamy B, Williams N.
Suresh A, et al. Among authors: berger m.
Invest New Drugs. 2020 Oct;38(5):1605-1611. doi: 10.1007/s10637-020-00891-9. Epub 2020 Jan 14.
Invest New Drugs. 2020.
PMID: 31938949